Moderna slashes 2025 sales forecast, shares sink

Jan 13, 2025 · Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects sales …

CouponFollow Extension

20%
OFF

Moderna Slashes 2025 Sales Forecast, Shares Sink

2 weeks from now

Jan 13, 2025 · Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects sales …

proactiveinvestors.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Jan 13, 2025 · Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion ... He said Moderna's share of the U.S. retail market for Covid shots fell to 40% at …

nbclosangeles.com

20%
OFF

Moderna Slashes 2025 Forecast, Stock Sinks 20%

2 weeks from now

Jan 13, 2025 · Moderna has lowered its 2025 revenue outlook from an estimated $2.5–$3.5 billion to just $1.5–$2.5 billion, citing hurdles like increased Covid competition and dwindling …

brandvm.com

$1
OFF

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

Jan 13, 2025 · Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion. The company expects much of its revenue to be realized in the back half of the …

investopedia.com

$3
OFF

Moderna Shares Sink After Vaccine Maker Slashes 2025 Revenue …

2 weeks from now

Jan 13, 2025 · In November, Moderna said it expects to report 2024 sales of $3 billion to $3.5 billion despite the business making less from its COVID vaccine than in the prior year.

investing.com

$1
OFF

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

2 weeks from now

Jan 13, 2025 · Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 …

reuters.com

20%
OFF

Moderna Slashes 2025 Sales Forecast, Shares Sink

2 weeks from now

Jan 13, 2025 · Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. ... Moderna slashes 2025 …

proactiveinvestors.co.uk

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

Jan 14, 2025 · Moderna reduced its previously announced sales guidance for 2025 by $1 billion. It now forecasts total revenues in the range of $1.5 to $2.5 billion, mainly from product sales of …

nasdaq.com

17%
OFF

Moderna Shares Sink After Vaccine Maker Slashes 2025 Revenue …

2 weeks from now

Jan 13, 2025 · Investing.com - Moderna (NASDAQ: MRNA) shares slumped by more than 17% in premarket US trading on Monday after the drugmaker slashed its revenue guidance for 2025. …

investing.com

$3
OFF

Moderna Provides Business And Pipeline Updates At 43rd Annual …

2 weeks from now

Jan 13, 2025 · Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited) Updates 2025 expected revenue range to …

modernatx.com

$1
OFF

Moderna Shares Drop To Five-Year Low After Slashing Revenue, …

2 weeks from now

Jan 13, 2025 · Moderna, which makes the Spikevax RNA-based Covid-19 vaccine, said before the bell it now expects between $1.5 billion and $2.5 billion in revenue in 2025, down from a …

marketwatch.com

20%
OFF

Moderna Slashes 2025 Sales Forecast, Shares Sink

2 weeks from now

Jan 14, 2025 · Moderna slashes 2025 sales forecast, shares sink Published: 06:02 14 Jan 2025 AEDT Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the …

proactiveinvestors.com.au

20%
OFF

Moderna Slashes 2025 Sales Forecast, Shares Sink

2 weeks from now

Jan 14, 2025 · Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects...

proactiveinvestors.com.au

9%
OFF

Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance …

2 weeks from now

3 days ago · Shares set undercut their 50-day line as they tested a two-year low, ... sales climbed 7% to $15.62 billion and topped analysts' forecast for $15.49 billion. ... 2025 Guidance Comes …

investors.com

3%
OFF

Walmart | Save Money. Live Better.

2 weeks from now

Up to 3% cash back · Shop Walmart today for Every Day Low Prices. Join Walmart+ for unlimited free delivery from your store & free shipping with no order minimum. Start your free …

FAQs about Moderna slashes 2025 sales forecast, shares sink Coupon?

Why did Moderna cut its 2025 sales forecast?

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than 24% in early trading. ...

Why did Moderna's shares tumble in early trading Monday?

(AP Photo/Eugene Hoshiko, File) Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. ...

How much money will Moderna save compared to 2023?

At the same time, we reduced our cash operating cost by over 25 percent compared to 2023 and aim to reduce 2025 cash costs by $1 billion with a plan for an additional $500 million cost savings in 2026," said Stéphane Bancel, Chief Executive Officer of Moderna. ...